Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
16 Aug 2024 |
CS01 |
Confirmation statement made on 16 August 2024 with no updates
|
|
|
07 Jun 2024 |
CS01 |
Confirmation statement made on 24 May 2024 with updates
|
|
|
31 May 2024 |
PSC05 |
Change of details for Haleon Uk Finance Limited as a person with significant control on 31 May 2024
|
|
|
15 May 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
07 Jun 2023 |
CS01 |
Confirmation statement made on 24 May 2023 with updates
|
|
|
05 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022
|
|
|
05 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022
|
|
|
30 May 2023 |
PSC05 |
Change of details for Glaxosmithkline Consumer Healthcare Finance Limited as a person with significant control on 14 April 2023
|
|
|
27 May 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
17 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023
|
|
|
17 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023
|
|
|
17 Mar 2023 |
CERTNM |
Company name changed gsk consumer healthcare capital uk PLC\certificate issued on 17/03/23
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2023-03-07
|
|
|
17 Nov 2022 |
CH01 |
Director's details changed for Mr Michael John Rowe on 18 July 2022
|
|
|
18 Jul 2022 |
AD01 |
Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022
|
|
|
07 Jul 2022 |
AP03 |
Appointment of Mrs Amanda Jane Mellor as a secretary on 4 July 2022
|
|
|
06 Jul 2022 |
TM02 |
Termination of appointment of Victoria Anne Whyte as a secretary on 4 July 2022
|
|
|
01 Jul 2022 |
AA |
Audit exemption subsidiary accounts made up to 31 December 2021
|
|
|
01 Jul 2022 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/21
|
|
|
01 Jul 2022 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 31/12/21
|
|
|
01 Jul 2022 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 31/12/21
|
|
|
24 May 2022 |
CS01 |
Confirmation statement made on 24 May 2022 with no updates
|
|
|
06 Apr 2022 |
TM01 |
Termination of appointment of Wellcome Foundation Limited(The) as a director on 6 April 2022
|
|
|
06 Apr 2022 |
TM01 |
Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 6 April 2022
|
|
|
06 Apr 2022 |
AP02 |
Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 6 April 2022
|
|
|
06 Apr 2022 |
AP02 |
Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022
|
|